Clin2
NCT07223684Possibly a fitNot yet recruiting

Tdap vaccine in burn patients

SepsisBurn InjuryWound HealingCritical IllnessMultiple Organ Dysfunction Syndrome

Part of Infections, Injuries & trauma, Lungs & breathing clinical trials.

This trial tests whether giving the Tdap vaccine (a combined vaccine against tetanus, diphtheria, and whooping cough) to burn patients is safe and works well. It aims to see if the vaccine can help prevent infections in burn wounds.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are 18 to 80 years old
  • You have a burn covering more than 10% of your body
  • You are being treated at a participating hospital (Emory/Grady, USF, or USAISR)
  • You can give consent, or a legal representative can consent for you
  • You are not pregnant
  • You are not a prisoner

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07249762Not yet recruiting
Burn recovery study with sepsis risk monitoring

This study collects tissue and blood samples from burn patients to improve a computer model that predicts sepsis (a severe infection). The goal is to help doctors identify and treat sepsis earlier in burn patients.

Tampa, Florida
NCT07866521Not yet recruiting
Monitoring infection markers in severely burned patients

This study tracks blood markers of infection in severely burned patients in the ICU. The goal is to see if these markers can help doctors detect sepsis earlier and guide treatment.

Lubbock, Texas
NCT07677657Not yet recruiting
Camera imaging to assess recent burns

This study tests a special camera that takes pictures of burns to help doctors see how deep they are. It is for people with recent heat burns on their head, hands, or feet, and aims to improve how doctors decide on treatment.

NCT07492303Not yet recruiting· Phase 1
Vaccine for whooping cough, diphtheria, and tetanus in teens and adults

This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.

NCT07112144Recruiting· Phase 3
DTaP vaccine trial for healthy infants aged 2 months

This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.

Wenshan Zhuang and Miao Autonomous Prefecture, Yunnan
NCT07744347Not yet recruiting
Long-term protection study of a combined vaccine

This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.